Pvg Asset Management Corp Milestone Pharmaceuticals Inc. Transaction History

Pvg Asset Management Corp

  • $21.3 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024
BUY
$1.29 - $1.65 $39,145 - $50,069
30,345 New
30,345 $46,000
Q4 2023

Mar 12, 2024
BUY
$1.67 - $3.39 $6,538 - $13,271
3,915 Added 25.41%
19,320 $32,000
Q2 2023

Jul 31, 2023
SELL
$2.85 - $4.4 $1,225 - $1,892
-430 Reduced 2.72%
15,405 $43,000
Q1 2023

Jul 24, 2023
BUY
$3.14 - $4.2 $49,721 - $66,507
15,835 New
15,835 $62,000

Others Institutions Holding MIST

# of Institutions
50
Shares Held
17M
Call Options Held
341K
Put Options Held
70.3K
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $49.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email